Clinical Trial Update: Transcranial Electromagnetic Treatment Against Alzheimer's Disease [NA]

View source ↗

Summary

Clinical trial evaluating a transcranial electromagnetic treatment for Alzheimer disease has completed, sponsored by NeuroEM Therapeutics, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Late-onset

Drugs mentioned

• Transcranial Electromagnetic Treatment

Snippet

Sponsor: NeuroEM Therapeutics, Inc. | Conditions: Alzheimer Disease, Alzheimer Disease, Late Onset | NA | Status: COMPLETED